Prostatic Neoplasms: all 6,484 studies
Page 3 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT07562438Phase 2
- PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian CohortNot yet recruitingNCT07560215
- Theranostic Applications of Radionuclides in Prostate CancerRecruitingNCT07559201Not applicable
- A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic ProphylaxisEnrolling by invitationNCT07557901Not applicable
- Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid TumorsNot yet recruitingNCT07555600Not applicable
- Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate CancerRecruitingNCT07553780
- Plasma Exosomal RNA Signature for Prostate Cancer Bone MetastasisRecruitingNCT07553754
- Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1RecruitingNCT07552922Not applicable
- The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single CenterRecruitingNCT07552285
- INSPIRE: INnovative SABR for Prostate Cancer All IRElandRecruitingNCT07552168Phase 2
- Cannabidiol for Pain Relief of Patients With End-stage mCRPCRecruitingNCT07549256Phase 2
- Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerRecruitingNCT07548164Phase 3
- Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07545811Phase 1
- Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of ProclarixRecruitingNCT07543757
- A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadRecruitingNCT07543055Phase 1
- The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate CancerRecruitingNCT07542379Early Phase 1
- A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical ProstatectomyRecruitingNCT07541911Not applicable
- Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer PatientsRecruitingNCT07535905Phase 2
- A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)RecruitingNCT07535541Not applicable
- Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate CancerRecruitingNCT07531329
- First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate CancerRecruitingNCT07529717Phase 1/2
- The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS StudyNot yet recruitingNCT07529418
- Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate CancerRecruitingNCT07526675Not applicable
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE TrialRecruitingNCT07526545Not applicable
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsRecruitingNCT07523529Phase 1/2
- The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical ProstatectomyRecruitingNCT07520916Not applicable
- Exercise-induced Steroid Changes in Active Surveillance for Prostate CancerRecruitingNCT07518888Not applicable
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
- Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical ProstatectomyRecruitingNCT07516886
- PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear MicroscopyNot yet recruitingNCT07516808Not applicable
- Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical StudyNot yet recruitingNCT07516704Early Phase 1
- Adaptive Radiotherapy for Safe HypofractionationNot yet recruitingNCT07516210Phase 2
- Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment ToxicityNot yet recruitingNCT07515651Phase 2
- A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate CancerNot yet recruitingNCT07512076Phase 2
- Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate CancerNot yet recruitingNCT07510906Not applicable
- GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate CancerRecruitingNCT07504835Not applicable
- Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate CancerRecruitingNCT07500701Phase 3
- Ultra-hypofractionated Carbon-ion Therapy for Prostate CancerNot yet recruitingNCT07495293Phase 1
- Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate CancerRecruitingNCT07493512Phase 1
- A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate CancerNot yet recruitingNCT07492381Not applicable
- Effect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted ProstatectomyRecruitingNCT07491198
- 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer PatientsNot yet recruitingNCT07485881
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in AlgeriaRecruitingNCT07484971
- PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide TetraxetanNot yet recruitingNCT07484269
- Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.RecruitingNCT07483658Not applicable
- A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological SurgeryNot yet recruitingNCT07480044Not applicable
- Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)Not yet recruitingNCT07478536
- Radiotherapy After Prostatectomy for Node Positive Prostate CancerRecruitingNCT07477626Phase 3
- Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate CancerNot yet recruitingNCT07476677Phase 2
- Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical ProstatectomyNot yet recruitingNCT07475533Not applicable
- A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate CancerRecruitingNCT07474142
- Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical TrialsEnrolling by invitationNCT07474051
- Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate CancerRecruitingNCT07468903Not applicable
- Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder CancerNot yet recruitingNCT07468838
- The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate CancerRecruitingNCT07468708Early Phase 1
- A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate CancerNot yet recruitingNCT07468396Phase 1
- Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP TrialRecruitingNCT07466498Phase 2
- Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation OncologyRecruitingNCT07463833Not applicable
- Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation TherapyRecruitingNCT07463092Not applicable
- Comparison of TB+PB and TB+6SB for Prostate Cancer DiagnosisRecruitingNCT07460843Not applicable
- PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate CancerNot yet recruitingNCT07460726
- Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTRecruitingNCT07455903Phase 2
- Water Vapor Ablation for Prostate Cancer: Long-Term RegistryRecruitingNCT07455058
- A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground TruthRecruitingNCT07454603
- SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPCRecruitingNCT07451795Phase 2
- A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in FranceRecruitingNCT07451002
- Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot yet recruitingNCT07444983Not applicable
- HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)RecruitingNCT07441889Phase 1/2
- Terbium 161 PSMA in Lutetium-177 PSMA Naive PatientsNot yet recruitingNCT07441837Phase 2
- RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer)Not yet recruitingNCT07440641Not applicable
- Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate CancerEnrolling by invitationNCT07439913
- Cancer Literacy Education and Awareness Resources for Prostate CareNot yet recruitingNCT07437482
- Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer SurvivorsRecruitingNCT07436078Not applicable
- Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive HistopathologyRecruitingNCT07432360
- Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)RecruitingNCT07427043Phase 3
- Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy IncontinenceRecruitingNCT07426861Not applicable
- PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate CancerRecruitingNCT07426094Phase 2/3
- PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate CancerRecruitingNCT07426055Phase 2/3
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07424547Phase 1
- Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate CancerRecruitingNCT07422597Not applicable
- ACTinium in Castrate-RESistant Prostate Cancer After LUTEtiumRecruitingNCT07414940Phase 1/2
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Screening and Staging of Benign vs Malignant Pelvic AbnormalitiesRecruitingNCT07407959
- Improving Engagement From Underserved Communities With Prostate Cancer Genetics ServicesNot yet recruitingNCT07407686
- ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0RecruitingNCT07407608
- A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate CancerRecruitingNCT07407283Phase 1/2
- A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology ClinicsRecruitingNCT07406282
- INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer DiagnosisRecruitingNCT07398690Not applicable
- Androgen-responsive POSLUMA-guided Intra-prostatic BoostRecruitingNCT07393867Phase 2
- Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two FractionsRecruitingNCT07391982Not applicable
- Pharmaceutical Management in Targeted Radioligand TherapyRecruitingNCT07389512
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic TestingRecruitingNCT07387263Not applicable
- The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRINot yet recruitingNCT07386496Not applicable
- Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active SurveillanceNot yet recruitingNCT07386171Not applicable
- Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Not yet recruitingNCT07381582Early Phase 1
- Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate CancerRecruitingNCT07377006Not applicable
- Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate CancerNot yet recruitingNCT07376057
- LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.RecruitingNCT07370597
- Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance ImagingRecruitingNCT07369570Not applicable